Back
ESC Premium Access

Predictive value of macrophage migration inhibitory factor (MIF) in heart failure with preserved ejection fraction (HFpEF)

Session: Poster Session 4 - Chronic heart failure – pathophysiology and mechanisms
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Speaker: Doctor P. Ludike (Osnabrueck, DE)
Event: ESC Congress 2018

Congress Presentation

About the speaker

Doctor Peter Ludike

Marienhospital Osnabrueck, Osnabrueck (Germany)
0 follower

21 more presentations in this session

Effects of mineralocorticoid receptor antagonists on diastolic function and exercise capacity in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials

Speaker: Associate Professor H. Fukuta (Nagoya, JP)

Access
Abstract
Thumbnail

Prognostic value of soluble ST2 biomarker in heart failure patients with preserved ejection fraction

Speaker: Doctor K. Kopeva (Tomsk, RU)

Access
Abstract
Slides
Thumbnail

Astragaloside IV reduces cardiac oxidation and improves left ventricular diastolic dysfunction

Speaker: Doctor Q. Wang (Lanzhou, CN)

Access
Abstract
Thumbnail

Long non coding RNA levels in hypertensive patients with heart failure with preserved ejection fraction and their relation to their functional capacity

Speaker: Associate Professor M. Marketou (Heraklion, GR)

Access
Abstract
Slides
Thumbnail

Morphological and functional changes in cardiovascular system in heart failure with preserved ejection fraction.

Speaker: Doctor M. Kurkina (Moscow, RU)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster Session 4 - Chronic heart failure – pathophysiology and mechanisms

Speakers: Doctor P. Ludike, Associate Professor H. Fukuta, Doctor K. Kopeva, Doctor Q. Wang, Associate Professor M. Marketou...
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb